Canada’s IWK Health Centre has deployed Masimo SET pulse oximetry and sensor technologies to improve patient care.
Masimo SET pulse oximetry reduces false alarms and enhances each clinician’s ability to notice life-threatening events, thereby contributing to enhanced patient outcomes and patient safety.
The hospital will use the technology for reducing retinopathy of prematurity, screening for critical congenital heart disease in newborns and saving lives in post-surgical floors, recovery, labour and delivery rooms and ICUs.
IWK Health Centre technology assessment officer David Hancock said, as the medical centre is specialised in children’s and women’s health, it is important to use the technology that provides a reliable and precise measure of blood oxygen saturation levels.
"We have standardised on Masimo technology in our ICUs, ORs and inpatient care areas for all patient monitoring, which will lead to improved patient outcomes," Hancock added.
With the Masimo SET technology, clinicians can precisely monitor blood oxygen saturation even during patient movement and low peripheral perfusion.
IWK has the option to upgrade to Masimo rainbow Pulse CO-Oximetry, which aids in noninvasive monitoring of multiple blood constituents such as total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet), Pleth Variability Index (PVI) and acoustic respiration rate (RRa).
Masimo founder and CEO Joe Kiani said: "We value this relationship with IWK, and together look forward to helping their skilled and dedicated staff meet and exceed their patient-care needs."